Sonova Audiological Care Denmark ApS - CVR: 16753181

2022, DKK

04.07.2023

Bruttoresultat

62.865'

Primær drift

-26.511'

Årets resultat

-29.724'

Aktiver

85.464'

Kortfristede aktiver

38.239'

Egenkapital

14.964'

Afkastningsgrad

-31 %

Soliditetsgrad

18 %

Likviditetsgrad

67 %

Resultat

04.07.2023

Årsrapport	2022 04.07.2023	2021 22.07.2022	2020 16.07.2021	2019 16.07.2020	2018 10.07.2019	2017 29.06.2018	2016 21.09.2017	2015 25.06.2016
Nettoomsætning	200.089.000	174.970.000	186.586.000	198.743.000	184.496.000	163.998.000	191.256.127	133.142.704
Bruttoresultat	62.865.000	56.595.000	89.098.000	79.008.000	0	0	61.931.715	53.905.183
Resultat af primær drift	-26.511.000	-25.623.000	5.448.000	-2.366.000	-17.225.000	-26.304.000	-32.775.618	-7.775.392
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0
Finansielle indtægter	0	0	0	0	0	905.000	160.887	0
Finansieringsomkostninger	-698.000	-148.000	-378.000	-1.358.000	-1.214.000	-1.328.000	-3.727.483	-3.981.849
Andre finansielle omkostninger	0	0	0	0	0	0	0	0
Resultat før skat	-27.209.000	-25.771.000	5.070.000	-3.724.000	-18.440.000	-26.727.000	-36.342.214	-11.757.241
Resultat	-29.724.000	-26.441.000	6.500.000	-3.840.000	-17.774.000	-19.161.000	-36.462.813	-11.706.513
Forslag til udbytte	0	0	0	0	0	0	0	0

Aktiver

04.07.2023

Årsrapport	2022 04.07.2023	2021 22.07.2022	2020 16.07.2021	2019 16.07.2020	2018 10.07.2019	2017 29.06.2018	2016 21.09.2017	2015 25.06.2016
Kortfristede varebeholdninger	13.812.000	14.395.000	12.671.000	13.951.000	23.154.000	9.643.000	8.892.768	16.506.390
Kortfristede tilgodehavender fra salg og tjenesteydelser	23.100.000	21.585.000	48.275.000	37.537.000	26.891.000	11.593.000	10.169.526	14.397.574
Likvider	1.327.000	1.934.000	802.000	234.000	1.228.000	1.886.000	6.985.562	9.287.375
Kortfristede aktiver	38.239.000	37.914.000	61.748.000	51.723.000	51.273.000	23.122.000	26.047.856	40.191.339
Immaterielle aktiver og goodwill	17.491.000	21.267.000	25.043.000	28.820.000	31.778.000	32.824.000	14.415.429	28.557.917
Finansielle anlægsaktiver	13.148.000	8.846.000	3.793.000	3.857.000	3.978.000	10.165.000	3.126.862	3.079.442
Materielle aktiver	16.586.000	17.649.000	14.585.000	21.127.000	15.468.000	17.110.000	14.966.955	12.347.669
Langfristede aktiver	47.225.000	47.762.000	43.421.000	53.804.000	51.224.000	60.099.000	32.509.246	43.985.028
Aktiver	85.464.000	85.676.000	105.169.000	105.527.000	102.496.000	83.221.000	58.557.102	84.176.367

Aktiver

04.07.2023

Passiver

04.07.2023

Årsrapport	2022 04.07.2023	2021 22.07.2022	2020 16.07.2021	2019 16.07.2020	2018 10.07.2019	2017 29.06.2018	2016 21.09.2017	2015 25.06.2016
Forslag til udbytte	0	0	0	0	0	0	0	0
Egenkapital	14.964.000	14.688.000	35.129.000	28.629.000	10.469.000	3.268.000	-17.497.656	-532.734
Hensatte forpligtelser	1.688.000	2.383.000	2.620.000	2.843.000	2.771.000	703.000	10.038.559	907.370
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld		0	7.206.000	4.439.000	0	0	0	0
Leverandører af varer og tjenesteydelser	5.848.000	8.668.000	4.529.000	5.449.000	1.916.000	6.824.000	9.292.243	2.972.558
Kortfristede forpligtelser	57.280.000	58.273.000	49.232.000	31.267.000	50.338.000	40.332.000	35.471.488	13.435.806
Gældsforpligtelser	68.812.000	68.605.000	67.420.000	76.898.000	89.257.000	79.250.000	66.016.199	83.801.731
Forpligtelser	68.812.000	68.605.000	67.420.000	76.898.000	89.257.000	79.250.000	66.016.199	83.801.731
Passiver	85.464.000	85.676.000	105.169.000	105.527.000	102.496.000	83.221.000	58.557.102	84.176.367

Passiver

04.07.2023

Nøgletal

04.07.2023

Årsrapport	2022 04.07.2023	2021 22.07.2022	2020 16.07.2021	2019 16.07.2020	2018 10.07.2019	2017 29.06.2018	2016 21.09.2017	2015 25.06.2016
Afkastningsgrad	-31,0 %	-29,9 %	5,2 %	-2,2 %	-16,8 %	-31,6 %	-56,0 %	-9,2 %
Dækningsgrad	31,4 %	32,3 %	47,8 %	39,8 %	Na.	Na.	32,4 %	40,5 %
Resultatgrad	-14,9 %	-15,1 %	3,5 %	-1,9 %	-9,6 %	-11,7 %	-19,1 %	-8,8 %
Varelagerets omsætningshastighed	14,5	12,2	14,7	14,2	8,0	17,0	21,5	8,1
Egenkapitals-forretning	-198,6 %	-180,0 %	18,5 %	-13,4 %	-169,8 %	-586,3 %	208,4 %	2.197,4 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-3.798,1 %	-17.312,8 %	1.441,3 %	-174,2 %	-1.418,9 %	-1.980,7 %	-879,3 %	-195,3 %
Soliditestgrad	17,5 %	17,1 %	33,4 %	27,1 %	10,2 %	3,9 %	-29,9 %	-0,6 %
Likviditetsgrad	66,8 %	65,1 %	125,4 %	165,4 %	101,9 %	57,3 %	73,4 %	299,1 %

Resultat

04.07.2023

Gæld

04.07.2023

Årsrapport

04.07.2023

Nyeste:01.04.2022- 31.03.2023(offentliggjort: 04.07.2023)

Beretning

04.07.2023

Dato for ledelsens godkendelse af årsrapporten:2023-06-28

Ledelsespåtegning:Statement by the the Executive Board

Beskrivelse af usikkerhed ved indregning eller måling:Financial risksOperating risksThe effects of fluctuations in the economy (expansion or recession) are expected to be limited for the Company, due to the fact that the dependency on the economic cycle is not specific high. The Company acts in a healthcare market, where the dependency on the reimbursement system is large. Changes in legislation can lead to significant impact on the result of the Company. The Company holds sufficient liquidity to ensure the fulfillment of all planned payment obligations. The amount of the liquidity reserve is regularly reviewed and adjusted as necessary according to circumstances. The parent company has provided letter of support with the intention to provide the Company with sufficient funds until 25 October 2024, to enable the Company to meet its working capital requirements. Exchange rate risksThe Company is not significantly exposed to currency rate risks, since purchases take place in EUR and DKK while sales only take place in DKK. The Company døs not hold any reserves in other currencies. Credit risksThe Company is not exposed to significant credit risks. The larger portion of the outstandings are Regions and/or Municipalities.

Oplysning om usædvanlige forhold:Unusual mattersUnusual items comprise significant income and expenses of a special nature relative to the Company's revenue-generating operating activities, e. g. expenses incurred for extensive structuring of processes and basic structural adjustments as well as any related disposal gains and losses, that have a material impact over time. Unusual items also comprise significant one-off items that, in Management's opinion, do not form part of the Company's operating activities. In 2022/23 the Company has costs of DKK 4,738 thousand related to restructuring of the revenue-generating operating activities. The cost is recognised in Other external expenses. The deferred tax assets have decreased by DKK 3,409 thousand. This is mainly due to the changes in the expected ability to utilize the tax asset within a period of 3-5 years.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, the Executive Board has discussed and approved the annual report of Sonova Audiological Care Denmark ApS for the financial year 1 April 2022 to 31 March 2023 .

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The principal activities of the companyThe Company's main activity is sales of hearing aid and related services.